05/02/2024 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Intelmed LLC (Reporting) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/24/2024 4:00 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Tapolczay David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 4:27 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/01/2024 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form NT 10-K | |
|
02/12/2024 11:51 AM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G/A | |
02/08/2024 12:15 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13G/A | |
01/10/2024 3:43 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/18/2023 3:14 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 424B3 | |
12/17/2023 11:15 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form EFFECT | |
12/14/2023 4:16 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Lewis-Hall Freda C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Sragovicz Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Tapolczay David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) McNealey Jennifer Isacoff (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 4:20 PM | Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 3:50 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1/A | |
12/01/2023 3:52 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2023 7:37 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q/A | |
11/20/2023 4:29 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/17/2023 3:49 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
10/05/2023 4:25 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-K/A | |
10/02/2023 3:30 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Nirland Ltd (Filed by)
| Form SC 13G | |
09/26/2023 4:37 PM | Algo Holdings, Inc. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Corvus Capital Ltd. (Reporting) Regan Andrew (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/26/2023 4:41 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Intelmed LLC (Reporting) Lewis-Hall Freda C (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/26/2023 4:42 PM | Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/26/2023 4:43 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) McNealey Jennifer Isacoff (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/26/2023 4:49 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Farley Chele Chiavacci (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 4:30 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Heilbron Jack Kendrick (Reporting) Murphy Canyon Acquisition Sponsor, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/26/2023 4:34 PM | Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/26/2023 4:34 PM | CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Tapolczay David (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/22/2023 3:32 PM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form CERT | |
09/22/2023 3:33 PM | CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/22/2023 8:25 AM | CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer) CONDUIT PHARMACEUTICALS INC. (Filer)
| Form 8-A12B | |
09/13/2023 12:53 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 12:56 PM | Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject) Murphy Canyon Acquisition Corp. (Subject)
| Form 425 | |
09/13/2023 12:59 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 424B3 | |
09/07/2023 3:31 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
09/07/2023 3:31 PM | Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject) Murphy Canyon Acquisition Corp. (Subject)
| Form 425 | |
08/31/2023 4:21 PM | Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject) Murphy Canyon Acquisition Corp. (Subject)
| Form 425 | |
08/23/2023 3:30 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 424B3 | |
08/23/2023 3:36 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2023 3:39 PM | Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject) Murphy Canyon Acquisition Corp. (Subject)
| Form 425 | |
08/16/2023 7:30 AM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2023 7:31 AM | Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject) Murphy Canyon Acquisition Corp. (Subject)
| Form 425 | |
08/14/2023 4:14 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2023 11:15 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form EFFECT | |
07/21/2023 4:15 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/21/2023 4:15 PM | Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject) Murphy Canyon Acquisition Corp. (Subject)
| Form 425 | |
07/11/2023 3:35 PM | Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer) Murphy Canyon Acquisition Corp. (Filer)
| Form S-4/A | |